顯示第 17 至 29 項結果，共 29 項
-
Anti-CD52 [Campath-1H] (Ab00124-26.0-BT)
-
Anti-CD52 [Campath-1H] (Ab00124-26.0)
-
Anti-CD8 [YTC 182.20] (Ab01039-26.0-BT)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-26.0-BT)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-26.0)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-37.0-BT)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-37.0)
-
Anti-Glycoprotein Complex [37.7H] (Ab01102-26.0-BT)
-
Anti-Glycoprotein Complex [37.7H] (Ab01102-26.0)
-
Anti-IL-2R [Daclizumab] (Ab00187-26.0-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-26.0)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-26.0-BT)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-26.0)